The downregulation of HPGD is associated with increased levels of PGE2 in the tumour microenvironment, leading to the increased proliferation and survival of hepatocytes, which contributes to the development of HCC from metabolic dysfunction-associated steatohepatitis (Hu et al., 2023). This evidence concerns the gene HPGD and neoplasm.